Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis. [PDF]
Zhang Y +4 more
europepmc +1 more source
Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up. [PDF]
Baumgarten T +10 more
europepmc +1 more source
Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. [PDF]
Liu L, Xu Q, Lin S, Wei Z, Huang G.
europepmc +1 more source
Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B. [PDF]
Li X +13 more
europepmc +1 more source
Expression and significance of INTS10 and IRF3 in chronic hepatitis B patients. [PDF]
Ye A, Chen X, Qiu D, Wu W.
europepmc +1 more source
New Insights into the Role of NF-κB in Hepatitis B Virus Infection. [PDF]
Halemubieke S +7 more
europepmc +1 more source
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical <i>in vivo</i> models. [PDF]
Noack J +11 more
europepmc +1 more source
Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center study. [PDF]
Cao F +19 more
europepmc +1 more source
Adaptive Evolution and Distinct Mutation Signatures of Full-Length HBV Quasispecies in HBeAg-Negative Chronic Hepatitis B. [PDF]
Wu C +8 more
europepmc +1 more source
Hepatitis B virus seromarkers as an unmet need for screening among patients in North India. [PDF]
Irfan S, Kumar P, Seema K.
europepmc +1 more source

